An interventional study of Integrated Model of Care in Concussion, Mild Traumatic Brain Injury, Brain Injury and Traumatic Brain Injury, sponsored by Shepherd Center, Atlanta GA. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Shepherd Center, Atlanta GA · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 420 studies in Brain Concussion with a site in United States — 102 open to participants now, 123 under way, 5 of them phase 3. Brain Concussion · United States.
Among the 420 studies in Brain Concussion with a site in United States, this one is the 29th largest by planned enrollment of the 323 interventional ones that give a count, is one of 27 that started in 2025, is one of 265 with no phase, reaches primary completion later than 96 of the 122 other live ones, and was the 365th registered.
641 studies on the registry are indexed under Brain Concussion; 167 are open to participants now.
Browse Brain Concussion studies →102 of the 420 studies in Brain Concussion with a site in United States are open now. Recruiting first, the newest first:
Johns Hopkins University · Sites in United States
Ages 18–55
HealthPartners Institute · Sites in United States
Ages 18–65
University of Michigan · Sites in United States
Ages 18+
Perception Dynamics Institute · Sites in United States
Ages 18–60
University of Colorado, Denver · Sites in United States
Ages 18+ · Men only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 114 Brain Concussion studies recruiting now, 34 (30%) set no upper age limit and 73 (64%) stop at 75 or younger; 24 take children under 18; 38 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
420 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 21 · Phase 2 29 · Phase 3 9 · Phase 4 5
First in 1998; this study’s year is marked. 27 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 360 is above the median of 63 across 449 interventional studies indexed under Brain Concussion.
Median enrollment 60 across the 323 interventional studies, 147 across the 96 observational. Of the 259 that completed or were terminated, 68 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
59 of 420 have an industry lead sponsor. The 10 most frequent:
Shepherd Center, Atlanta GA is the lead sponsor of 22 studies on the registry; 4 are open to participants now.
Shepherd Center, Atlanta GA has 1 study filed under Brain Concussion — fewer than ten, so there is no comparison to draw.
50 of the studies in Brain Concussion with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04867317Phase 3VA Office of Research and DevelopmentGrowth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) | 2027-02-28 |
| NCT05320822University of North Carolina, Chapel HillA Pragmatic Rehabilitation Intervention: The Active Rehab Study | 2026-11-28 |
| NCT06109909VA Office of Research and DevelopmentPilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury | 2026-11-30 |
| NCT02670161Endeavor HealthQuality Improvement and Practice Based Research in Neurology Using the EMR | 2026-12 |
| NCT04708613David Okonkwo, MD, PhDUniversity of Pittsburgh Brain Health Initiative | 2026-12 |
Add all 50 to your calendar (.ics) → With an account.
Among the 420 studies in Brain Concussion with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this research is to determine whether military veterans and service members with mild traumatic brain injury with and without co-occurring substance use can complete and benefit from integrated interdisciplinary care individualized to their symptoms, goals, and needs.
Participants will complete surveys about substance use and other symptoms at the beginning and end of treatment in an intensive outpatient program and 6 months after discharge.
This pragmatic clinical trial will (1) assess treatment retention and treatment outcomes at the completion of interdisciplinary intensive outpatient program (IOP) and at a 6-month follow-up comparing service members and veterans (SM/Vs) with mild traumatic brain injury (mTBI) + substance use (SU) and a TBI -control group; and (2) assess SU-related outcomes at the end of IOP treatment and durability of SU outcomes at 6-months follow-up among SM/Vs with co-occurring SU. Analyses of these key treatment outcomes along with input from lived experience consultants and other key stakeholders, will be used to refine and disseminate a scalable approach to treating individuals with mTBI and co-occurring SU.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will engage in interdisciplinary intensive outpatient program (IOP) treatment for mild traumatic brain injury with individualized support for substance use (SU) following which they will receive support for SU in the transition support program.
Other: Integrated Model of Care
The Integrated Model of Care was developed and piloted by the study team provide support for individuals seeking care in an interdisciplinary intensive outpatient program for mild traumatic brain injury to receive support for co-occurring substance use-related needs.
Neurobehavioral Symptom Inventory (NSI)
a 22-item, self-report questionnaire used to measure change in symptoms commonly associated with mild traumatic brain injury over time
Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up
Short Inventory of Problems- Revised (SIP-R)
a 17-item self-report inventory used to assess adverse consequences of substance use
Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up
Life-Satisfaction Questionnaire -11 (LISAT-11)
an internationally validated 11-item self-report inventory of satisfaction within important life domains: life as a whole, vocational situation, financial situation, leisure situation, contacts with friends, sexual life, self-care management, family life, partner, physical health, and psychological health
Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)
a 20-item self-report inventory used to assess severity of posttraumatic stress symptoms and monitoring symptom change during and after treatment
Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up
Patient Health Questionnaire (PHQ-8)
an eight item, self-report inventory used to screen for the presence and severity of depression
Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up
Generalized Anxiety Disorder Scale (GAD-7)
a seven item, self-report inventory used to screen for the presence and severity of anxiety
Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up
Repeatable Battery for the Assessment of Neuropsychological Status Update (RBANS Update)
a multi-item, multi-subtest, clinician administered objective assessment used to measure change over time in neuropsychological status by yielding a Total Score, as well as Immediate Memory, Delayed Memory, Attention, Language, and Visuospatial/ Constructional scores
Time frame: Study enrollment and immediately after the intervention
Sensory Organization Test (SOT)
completed as part of quantitative Balance Testing (Bertec) which provides information about postural stability by measuring subject sway on a force platform under different sensory conditions; the SOT is used to evaluate sensory weighting in postural control using a series of conditions of increased difficulty.
Time frame: Study enrollment and immediately after the intervention
Behavior Rating Inventory of Executive Functioning - Adult Version (BRIEF-A)
a 75-item self-report inventory of executive functioning in everyday environments that yields a total Global Executive Composite score as well as a Behavioral Regulation Index and Metacognitive Index
Time frame: Study enrollment and immediately after the intervention
Alcohol Use Disorders Identification Test- Concise (AUDIT-C)
a three-item, self-report screening tool used to identify people who with active alcohol use disorders (including alcohol abuse or dependence).
Time frame: Study enrollment and at 6 months follow-up
Drug Abuse Screening Test (DAST-10)
a 10-item self-report instrument that yields a quantitative index of the degree of consequences related to drug use
Time frame: Study enrollment and at 6 months follow-up
Cannabis Use Disorder Identification Test (CUDIT-R)
an 8-item measure designed for screening for problematic cannabis use and use a brief repeated outcome measure
Time frame: Study enrollment and at 6 months follow-up
National Survey on Drug Use and Health (NSDUH)- 30-day use: Alcohol and Substances
survey of alcohol use (tallying days used and estimating average number of drinks per drinking day) and additional substances used (number of days used)
Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — We will submit de-identified research data into the Federal Interagency TBI Research (FITBIR) Informatics System at the completion of the clinical trial. The following data will be collected and reported the following National Institute of Neurological Disorders and Stroke (NINDS) TBI common data elements (CDE) as part of this process: Demographics and Injury Characteristics Neurobehavioral Symptom Inventory (NSI) Alcohol Use Disorders Identification Test-Concise (AUDIT-C) Patient Health Questionnaire (8 Item) (PHQ-8) Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) Life-Satisfaction Questionnaire -11 (LISAT-11) Sensory Organization Test (SOT) Short Inventory of Problems- Revised (SIP-R) Drug Abuse Screening Test (DAST-10) Cannabis Use Disorder Identification Test (CUDIT-R) National Survey on Drug Use and Health (NSDUH)- 30-day use: Alcohol and Substances
Time frame: We will complete upload of IPD by Aug 31, 2025.
Access criteria: Researchers can then file an application with FITBIR, following FITBIR processes and protocols, to request access to the data for research purposes.
Started Mar 2025 (actual). Primary completion is estimated for Aug 2028, 41 months after the start.
Of 249 non-industry interventional studies with no phase under Brain Concussion, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 47. This study's planned 41 months is above that.
Counting every sponsor, half of 265 studies reached it within 28 months; a quarter within 19 and three quarters within 47.
Start moved once since we started tracking on Sep 25, 2026: Feb 2025 → Mar 2025, on Nov 18, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shepherd Center, Atlanta GA